354 related articles for article (PubMed ID: 11402222)
1. Mitochondrial toxicity and HIV therapy.
White AJ
Sex Transm Infect; 2001 Jun; 77(3):158-73. PubMed ID: 11402222
[TBL] [Abstract][Full Text] [Related]
2. Clinical manifestations and management of antiretroviral nucleoside analog-related mitochondrial toxicity.
Moyle G
Clin Ther; 2000 Aug; 22(8):911-36; discussion 898. PubMed ID: 10972629
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial dysfunction and nucleoside reverse transcriptase inhibitor therapy: experimental clarifications and persistent clinical questions.
Lewis W
Antiviral Res; 2003 May; 58(3):189-97. PubMed ID: 12767466
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy.
Brinkman K; Smeitink JA; Romijn JA; Reiss P
Lancet; 1999 Sep; 354(9184):1112-5. PubMed ID: 10509516
[TBL] [Abstract][Full Text] [Related]
5. Clinical manifestations of mitochondrial toxicity.
Walker UA
J HIV Ther; 2001 Mar; 6(1):17-21. PubMed ID: 11501197
[No Abstract] [Full Text] [Related]
6. Mitochondrial toxicity: myths and facts.
Moyle G
J HIV Ther; 2004 May; 9(2):45-7. PubMed ID: 15238876
[TBL] [Abstract][Full Text] [Related]
7. Long-term complications of nucleoside reverse transcriptase inhibitor therapy.
Dieterich DT
AIDS Read; 2003 Apr; 13(4):176-84, 187. PubMed ID: 12741368
[TBL] [Abstract][Full Text] [Related]
8. NRTI induced mitochondrial toxicity as a mechanism for HAART related lipodystrophy: fact or fiction?
Walker UA; Brinkman K
HIV Med; 2001 Jul; 2(3):163-5. PubMed ID: 11737396
[No Abstract] [Full Text] [Related]
9. A brief overview of mechanisms of mitochondrial toxicity from NRTIs.
Kohler JJ; Lewis W
Environ Mol Mutagen; 2007; 48(3-4):166-72. PubMed ID: 16758472
[TBL] [Abstract][Full Text] [Related]
10. Update on mitochondrial toxicity of antiretrovirals and its link to lipodystrophy.
McComsey G
AIDS Rev; 2002; 4(3):140-7. PubMed ID: 12416448
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial defects arise from nucleoside/nucleotide reverse transcriptase inhibitors in neurons: Potential contribution to HIV-associated neurocognitive disorders.
Hung KM; Chen PC; Hsieh HC; Calkins MJ
Biochim Biophys Acta Mol Basis Dis; 2017 Feb; 1863(2):406-413. PubMed ID: 27840304
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial toxicity of nucleoside analogues: mechanism, monitoring and management.
Cherry CL; Lala L; Wesselingh SL
Sex Health; 2005; 2(1):1-11. PubMed ID: 16334706
[TBL] [Abstract][Full Text] [Related]
13. Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity.
Kakuda TN
Clin Ther; 2000 Jun; 22(6):685-708. PubMed ID: 10929917
[TBL] [Abstract][Full Text] [Related]
14. NRTI-associated mitochondrial toxicity.
Landovitz RJ; Sax PE
AIDS Clin Care; 2001 May; 13(5):43-5, 48-9, 52. PubMed ID: 11682785
[No Abstract] [Full Text] [Related]
15. Cell culture models for the investigation of NRTI-induced mitochondrial toxicity. Relevance for the prediction of clinical toxicity.
Höschele D
Toxicol In Vitro; 2006 Aug; 20(5):535-46. PubMed ID: 16406476
[TBL] [Abstract][Full Text] [Related]
16. Impact of nucleoside reverse transcriptase inhibitors on mitochondria in human immunodeficiency virus type 1-infected children receiving highly active antiretroviral therapy.
Saitoh A; Fenton T; Alvero C; Fletcher CV; Spector SA
Antimicrob Agents Chemother; 2007 Dec; 51(12):4236-42. PubMed ID: 17893156
[TBL] [Abstract][Full Text] [Related]
17. Highly active antiretroviral therapy (HAART)-associated lactic acidosis: in vitro effects of combination of nucleoside analogues and protease inhibitors on mitochondrial function and lactic acid production.
Nerurkar PV; Pearson L; Frank JE; Yanagihara R; Nerurkar VR
Cell Mol Biol (Noisy-le-grand); 2003 Dec; 49(8):1205-11. PubMed ID: 14983988
[TBL] [Abstract][Full Text] [Related]
18. Anti-HIV drugs and the mitochondria.
Pinti M; Salomoni P; Cossarizza A
Biochim Biophys Acta; 2006; 1757(5-6):700-7. PubMed ID: 16782042
[TBL] [Abstract][Full Text] [Related]
19. Impact of mitochondrial toxicity of HIV-1 antiretroviral drugs on lipodystrophy and metabolic dysregulation.
Feeney ER; Mallon PW
Curr Pharm Des; 2010 Oct; 16(30):3339-51. PubMed ID: 20687890
[TBL] [Abstract][Full Text] [Related]
20. Possible ways nucleoside analogues can affect mitochondrial DNA content and gene expression during HIV therapy.
Côté HC
Antivir Ther; 2005; 10 Suppl 2():M3-11. PubMed ID: 16152702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
